Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Wien Klin Wochenschr. 2020 Feb;132(3-4):61-68. doi: 10.1007/s00508-019-01603-x. Epub 2020 Jan 29.
The development of new devices and treatment options has greatly increased the interest in heart valve diseases. In this context, the consideration of gender differences in diagnosis, treatment success, and prognosis is of great importance. Available data show that women and men with heart valve disease have different risk profiles, which have a significant impact on treatment outcomes and prognosis.It is the purpose of this review article to give an overview of gender-related differences in patients with valvular heart disease, regarding clinical presentation, treatment, and outcomes. In light of the emerging treatment possibilities, future research should emphasize the role of gender since both sexes benefit from tailored management.
新型器械和治疗方案的发展大大提高了人们对心脏瓣膜疾病的关注。在此背景下,考虑到诊断、治疗效果和预后方面的性别差异具有重要意义。现有数据表明,患有心脏瓣膜病的女性和男性具有不同的风险特征,这对治疗效果和预后有重大影响。本文旨在综述心脏瓣膜病患者的性别差异,包括临床表现、治疗和结局,以便对这一领域有更全面的了解。鉴于新兴的治疗可能性,未来的研究应强调性别因素的作用,因为两性都受益于针对性的管理。